BSPED2023 Oral Communications Oral Communications 9 (9 abstracts)
Quality improvement using PDSA cycles improves performance on NPDA key care processes for Birmingham Children’s Hospital
Holly Wood 1 , Lesley Drummond 1 , Louise Collins 1 , Donna Sands 1 , Renuka Dias 1,2 , Catarina Leal 1 , Marie McElroy 1 , Pauline Neylon 1 , Ruth Krone 1 , Melaine Kershaw 1 & John Pemberton 1
1Birmingham Children’s Hospital, Birmingham, United Kingdom. 2University of Birmingham, Birmingham, United Kingdom
Background: From 2018 to 2020, the Birmingham Children’s Hospital (BCH) Diabetes Team was a negative regional outlier for the National Paediatric Diabetes Audit (NPDA) seven key care processes. In 2021, the BCH team embarked on a Quality Improvement (QI) journey using Plan-Do-Study-Act (PDSA) cycles to improve care.
Objective: Review PDSA cycles of improvements from 2021 to 2023.
Methods: In 2021, the BCH team completed a national QI programme teaching PDSA cycles. The main change in 2021 was a revamped annual review clinic focussing on blood tests and care process delivery. In 2022, the review highlighted the annual review clinic only captured 60% of patients. Consequently, every clinic from May to September 2022 became an opportunity to target key care processes, focussing on annual screening blood tests and foot examinations, with reminders for arranging eye screening. The Operational Team reviewed the NPDA data quarterly, leading to data-driven adaptations of processes that the entire team embraced. This included phlebotomy attending the clinic, and regular clinic audits. We compared NPDA unit data for percentage completion of the seven individual key care processes for 2018, 2019, 2020, 2021 (COVID-19), 2022, and 2023 (unpublished). Additionally, we compared the percentage of those over 12 years of age with all seven completed processes for 2018, 2019, 2020, and 2021. Retinopathy screening national screening policy changed in 2021. Therefore, only the completion of six processes is reported for 2022 and 2023.
Conclusion: PDSA cycles and regular innovation moved the BCH team from a negative outlier from 2018 to 2021 to an above-average performer in 2022. The care process completion data for 2022-23 improved further.
Volume 95
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more